活细胞封装市场－全球产业规模、份额、趋势、竞争、机会和预测，按聚合物类型、应用、技术、地区和竞争细分，2020-2030 年

2024年，全球活细胞封装市场规模为2.54亿美元，预计2030年将达到10.47亿美元，预测期内复合年增长率为26.62%。这得益于许多因素，例如，在提高细胞封装技术有效性方面研发的不断深入，以及政府和私人投资对活细胞封装产品开发的支持力度不断加大。活细胞封装是一项生物工程技术，包括用材料或涂层包裹活细胞。用于封装的材料种类繁多，例如脂质体、水凝胶和微胶囊。

此外，活细胞封装在细胞疗法中具有重要意义，因为它可以控制生物活性物质或细胞的释放，因此预计随着全球细胞疗法的兴起，它将促进市场成长。

关键市场驱动因素

需要细胞疗法的慢性疾病发生率不断上升

主要市场挑战

免疫排斥和纤维化过度生长

主要市场趋势

再生医学和组织工程中封装技术的日益普及

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球活细胞封装市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依聚合物类型（海藻酸盐、壳聚醣、硫酸纤维素等）
  • 依应用（药物传输、再生医学、细胞移植和益生菌）
  • 按技术（简单滴灌、静电滴灌和同轴气流
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：亚太活细胞封装市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国 。
  • 印度 。
  • 韩国
  • 日本
  • 澳洲

第七章：欧洲活细胞封装市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第 8 章：北美活细胞封装市场展望。

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第九章：南美洲活细胞封装市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲活细胞封装市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 併购
• 产品开发

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品/服务的威胁

第 14 章：全球活细胞封装市场：SWOT 分析

第 15 章：竞争格局

• Merck KGaA
• Sphere Bio.
• Vertex Pharmaceuticals Incorporated
• Unchained Labs.
• BIO INX
• Algorae Pharmaceuticals Ltd
• Eli Lilly and Company
• Isogen Lifescience BV
• Diatranz Otsuka Ltd
• PHAXIAM Therapeutics SA

第 16 章：策略建议

第17章调查会社について・免责事项

Global Live Cell Encapsulation Market was valued at USD 254 million in 2024 and is expected to reach USD 1047 million by 2030 with a CAGR of 26.62% during the forecast period. This can be attributed to factors such as growing research & development in improving the effectiveness of cell encapsulation technologies, along with the rise in governmental and private investments supporting live cell encapsulated product development. Live cell encapsulation is a bioengineering technology which includes encasing living cells with a material or coating. A distinct variety of materials are used for the encapsulation such as liposomes, hydrogels, and microcapsules.

Moreover, live cell encapsulation is found to have significant importance in cell therapies as it allows a controlled release of bioactive material or cells and thereby is anticipated to bolster market growth with rise in cell therapies across the globe.

Key Market Drivers

Increasing Incidence of Chronic Diseases Requiring Cell-Based Therapies

One of the primary drivers fueling the live cell encapsulation market is the rising prevalence of chronic and non-communicable diseases (NCDs) such as diabetes, cancer, and neurological disorders. Encapsulation technology allows for the delivery of therapeutic cells, such as pancreatic islet cells, which are crucial for insulin production in type 1 diabetes. According to the World Health Organization (WHO), NCDs are responsible for over 74% of all global deaths, and nearly 422 million people globally have diabetes. A significant portion of this population requires lifelong insulin therapy, and live cell encapsulation offers a transformative solution through potential curative therapies.

The ability of encapsulated cells to provide sustained therapeutic benefit without provoking an immune response has made this technique increasingly important for regenerative medicine. Governments in high-burden countries have begun investing in regenerative medicine research. For example, the U.S. National Institutes of Health (NIH) allocated nearly $2 billion toward cell-based therapy and regenerative medicine research in recent years. Similarly, the European Commission supports cell-based innovation through its Horizon Europe program. These investments indicate growing public sector endorsement for technologies like cell encapsulation, particularly in chronic disease management.

Key Market Challenges

Immune Rejection and Fibrotic Overgrowth

Despite technological progress, one of the most persistent challenges in the live cell encapsulation market is immune rejection and fibrotic response that can limit the functional lifespan of encapsulated cells. While the encapsulation membrane is designed to shield cells from immune surveillance, over time the body may still recognize the foreign material and initiate fibrotic encapsulation, which leads to reduced nutrient exchange and eventual cell death.

This issue is particularly problematic in long-term applications such as pancreatic islet transplantation for diabetes or encapsulated neural cells for treating Parkinson's disease. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), clinical studies of islet transplantation show promising early results but often experience a decline in cell function over time due to immune-mediated encapsulation or fibrosis. This has limited the wide-scale clinical adoption of encapsulated cell therapies, especially in countries with stringent medical device approval processes.

Key Market Trends

Rising Use of Encapsulation in Regenerative Medicine and Tissue Engineering

A significant trend shaping the live cell encapsulation market is its expanding role in regenerative medicine and tissue engineering applications. Researchers are increasingly using encapsulated cells not only for drug delivery but also to repair or regenerate damaged tissues, including cartilage, cardiac muscle, and neuronal structures. The biocompatibility and immune-isolating properties of encapsulated cells make them highly suitable for transplantation in environments where immune rejection is a concern.

Governmental support for regenerative medicine is growing globally. For example, the U.S. 21st Century Cures Act allocates billions toward advancing regenerative therapies, and the European Union's Horizon Europe program continues to fund cross-border collaborative research in tissue regeneration. Encapsulation plays a central role in these initiatives, offering controlled, localized cell delivery and minimizing systemic side effects.

Key Market Players

• Merck KGaA
• Sphere Bio.
• Vertex Pharmaceuticals Incorporated
• Unchained Labs.
• BIO INX
• Algorae Pharmaceuticals Ltd
• Eli Lilly and Company
• Isogen Lifescience B.V.
• Diatranz Otsuka Ltd
• PHAXIAM Therapeutics S.A.

Report Scope:

In this report, the Global Live Cell Encapsulation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Live Cell Encapsulation Market, By Polymer Type:

• Alginate
• Chitosan
• Cellulose Sulfate
• Others

Live Cell Encapsulation Market, By Application:

• Drug Delivery
• Regenerative Medicine
• Cell Transplantation
• Probiotics

Live Cell Encapsulation Market, By Technique:

• Simple Dripping
• Electrostatic Dripping
• Coaxial Airflow

Live Cell Encapsulation Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Live Cell Encapsulation Market.

Available Customizations:

Global Live Cell Encapsulation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Live Cell encapsulation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Polymer Type (Alginate, Chitosan, Cellulose Sulfate and Others)
  • 5.2.2. By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation and Probiotics)
  • 5.2.3. By Technique (Simple Dripping, Electrostatic Dripping and Coaxial Airflow
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. Asia-Pacific Live Cell encapsulation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Polymer Type
  • 6.2.2. By Application
  • 6.2.3. By Technique
  • 6.2.4. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Live Cell encapsulation Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Polymer Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Technique
  • 6.3.2. India Live Cell encapsulation Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Polymer Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Technique
  • 6.3.3. South Korea Live Cell encapsulation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Polymer Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Technique
  • 6.3.4. Japan Live Cell encapsulation Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Polymer Type
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By Technique
  • 6.3.5. Australia Live Cell encapsulation Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Polymer Type
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By Technique

7. Europe Live Cell encapsulation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Polymer Type
  • 7.2.2. By Application
  • 7.2.3. By Technique
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Live Cell encapsulation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Polymer Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Technique
  • 7.3.2. Germany Live Cell encapsulation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Polymer Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Technique
  • 7.3.3. United Kingdom Live Cell encapsulation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Polymer Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Technique
  • 7.3.4. Italy Live Cell encapsulation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Polymer Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Technique
  • 7.3.5. Spain Live Cell encapsulation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Polymer Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Technique

8. North America Live Cell encapsulation Market Outlook.

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Polymer Type
  • 8.2.2. By Application
  • 8.2.3. By Technique
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Live Cell encapsulation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Polymer Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Technique
  • 8.3.2. Mexico Live Cell encapsulation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Polymer Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Technique
  • 8.3.3. Canada Live Cell encapsulation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Polymer Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Technique

9. South America Live Cell encapsulation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Polymer Type
  • 9.2.2. By Application
  • 9.2.3. By Technique
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Live Cell encapsulation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Polymer Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Technique
  • 9.3.2. Argentina Live Cell encapsulation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Polymer Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Technique
  • 9.3.3. Colombia Live Cell encapsulation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Polymer Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Technique

10. Middle East and Africa Live Cell encapsulation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Polymer Type
  • 10.2.2. By Application
  • 10.2.3. By Technique
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Live Cell encapsulation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Polymer Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Technique
  • 10.3.2. Saudi Arabia Live Cell encapsulation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Polymer Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Technique
  • 10.3.3. UAE Live Cell encapsulation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Polymer Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Technique

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Live Cell encapsulation Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Merck KGaA
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Sphere Bio.
• 15.3. Vertex Pharmaceuticals Incorporated
• 15.4. Unchained Labs.
• 15.5. BIO INX
• 15.6. Algorae Pharmaceuticals Ltd
• 15.7. Eli Lilly and Company
• 15.8. Isogen Lifescience B.V.
• 15.9. Diatranz Otsuka Ltd
• 15.10. PHAXIAM Therapeutics S.A.

16. Strategic Recommendations

17. About Us & Disclaimer